{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T08:38:39Z","timestamp":1793176719529,"version":"4.5.0"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2027,1]]},"DOI":"10.1016\/j.jneuroim.2026.579110","type":"journal-article","created":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T23:17:35Z","timestamp":1791587855000},"page":"579110","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["NOP58 knockdown in microglia is associated with reduced neuroinflammation and synaptic damage in NMOSD"],"prefix":"10.1016","volume":"422","author":[{"given":"Zongzong","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jneuroim.2026.579110_bb0005","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1093\/nar\/gkaa1226","article-title":"NOPCHAP1 is a PAQosome cofactor that helps loading NOP58 on RUVBL1\/2 during box C\/D snoRNP biogenesis","volume":"49","author":"Abel","year":"2021","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"10.1016\/j.jneuroim.2026.579110_bb0015","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1186\/s12974-021-02249-1","article-title":"Neuromyelitis optica spectrum disorders: from pathophysiology to therapeutic strategies","volume":"18","author":"Carnero Contentti","year":"2021","journal-title":"J. Neuroinflammation"},{"issue":"1","key":"10.1016\/j.jneuroim.2026.579110_bb0020","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000200188","article-title":"Serum biomarker profiles discriminate AQP4 seropositive and double seronegative Neuromyelitis Optica spectrum disorder","volume":"11","author":"Carta","year":"2024","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"8","key":"10.1016\/j.jneuroim.2026.579110_bb0025","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1007\/s12264-023-01166-y","article-title":"Serum LDL promotes microglial activation and exacerbates demyelinating injury in Neuromyelitis Optica Spectrum disorder","volume":"40","author":"Chen","year":"2024","journal-title":"Neurosci. Bull."},{"key":"10.1016\/j.jneuroim.2026.579110_bb0030","article-title":"The emerging role of microglia in Neuromyelitis Optica","volume":"12","author":"Chen","year":"2021","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.jneuroim.2026.579110_bb0035","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2022112699","article-title":"Ribosome biogenesis factors-from names to functions","volume":"42","author":"D\u00f6rner","year":"2023","journal-title":"EMBO J."},{"issue":"6","key":"10.1016\/j.jneuroim.2026.579110_bb0040","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1016\/j.cell.2020.08.003","article-title":"The human and mouse enteric nervous system at single-cell resolution","volume":"182","author":"Drokhlyansky","year":"2020","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.jneuroim.2026.579110_bb0045","doi-asserted-by":"crossref","first-page":"272","DOI":"10.2174\/1381612827666210329101335","article-title":"Recent advances in Neuromyelitis Optica Spectrum disorder: pathogenesis, mechanisms and potential treatments","volume":"28","author":"Du","year":"2022","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.jneuroim.2026.579110_bb0050","article-title":"Burden and cost of comorbidities in patients with neuromyelitis optica spectrum disorder","volume":"427","author":"Exuzides","year":"2021","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jneuroim.2026.579110_bb0055","article-title":"Effects of long-term magnesium L-threonate supplementation on neuroinflammation, demyelination and blood-brain barrier integrity in mice with neuromyelitis optica spectrum disorder","volume":"1846","author":"Fu","year":"2024","journal-title":"Brain Res."},{"key":"10.1016\/j.jneuroim.2026.579110_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2022.103527","article-title":"Serum molecular biomarkers in neuromyelitis optica and multiple sclerosis","volume":"59","author":"Fu","year":"2022","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.jneuroim.2026.579110_bb0065","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2016.00157","article-title":"Mammalian target of rapamycin: its role in early neural development and in adult and aged brain function","volume":"10","author":"Garza-Lomb\u00f3","year":"2016","journal-title":"Front. Cell. Neurosci."},{"issue":"8","key":"10.1016\/j.jneuroim.2026.579110_bb0070","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23084154","article-title":"Adverse events in NMOSD therapy","volume":"23","author":"Giglhuber","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.jneuroim.2026.579110_bb0075","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s00401-017-1682-1","article-title":"Pathogenic implications of cerebrospinal fluid barrier pathology in neuromyelitis optica","volume":"133","author":"Guo","year":"2017","journal-title":"Acta Neuropathol."},{"issue":"11","key":"10.1016\/j.jneuroim.2026.579110_bb0080","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20192550","article-title":"Long noncoding RNA FAM83A-AS1 facilitates hepatocellular carcinoma progression by binding with NOP58 to enhance the mRNA stability of FAM83A","volume":"39","author":"He","year":"2019","journal-title":"Biosci. Rep."},{"issue":"3","key":"10.1016\/j.jneuroim.2026.579110_bb0085","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/jnc.14576","article-title":"Ribosomal biogenesis as an emerging target of neurodevelopmental pathologies","volume":"148","author":"Hetman","year":"2019","journal-title":"J. Neurochem."},{"key":"10.1016\/j.jneuroim.2026.579110_bb0090","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ibneur.2024.07.008","article-title":"IL-33 relieves nerve injury by mediating microglial polarization in neuromyelitis optica spectrum disorders via the IL-33\/ST2 pathway","volume":"17","author":"Huang","year":"2024","journal-title":"IBRO Neurosci Rep"},{"issue":"1","key":"10.1016\/j.jneuroim.2026.579110_bb0095","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/s13023-022-02310-z","article-title":"Health utilities and costs for neuromyelitis optica spectrum disorder","volume":"17","author":"Hughes","year":"2022","journal-title":"Orphanet J. Rare Dis."},{"issue":"1","key":"10.1016\/j.jneuroim.2026.579110_bb0100","doi-asserted-by":"crossref","DOI":"10.1038\/s41572-020-0214-9","article-title":"Neuromyelitis optica","volume":"6","author":"Jarius","year":"2020","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"1","key":"10.1016\/j.jneuroim.2026.579110_bb0105","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/s41392-022-01285-4","article-title":"Ribosome biogenesis in disease: new players and therapeutic targets","volume":"8","author":"Jiao","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"issue":"2","key":"10.1016\/j.jneuroim.2026.579110_bb0110","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1136\/jnnp-2016-313300","article-title":"Neurodegeneration in multiple sclerosis and neuromyelitis optica","volume":"88","author":"Kawachi","year":"2017","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jneuroim.2026.579110_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2022.115303","article-title":"Antibiotic-disrupted ribosome biogenesis facilitates tumor chemokine superinduction","volume":"206","author":"Kim","year":"2022","journal-title":"Biochem. Pharmacol."},{"issue":"1","key":"10.1016\/j.jneuroim.2026.579110_bb0120","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1038\/s41598-024-51759-4","article-title":"Early involvement of peripherally derived monocytes in inflammation in an NMO-like mouse model","volume":"14","author":"Kim","year":"2024","journal-title":"Sci. Rep."},{"issue":"12","key":"10.1016\/j.jneuroim.2026.579110_bb0125","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.2798","article-title":"Microglial\/macrophage activation in the cerebrospinal fluid of neuromyelitis optica spectrum disorders","volume":"12","author":"Li","year":"2022","journal-title":"Brain Behav."},{"key":"10.1016\/j.jneuroim.2026.579110_bb0130","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2019.00587","article-title":"Small nucleolar RNAs: insight into their function in cancer","volume":"9","author":"Liang","year":"2019","journal-title":"Front. Oncol."},{"issue":"2","key":"10.1016\/j.jneuroim.2026.579110_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.101524","article-title":"RNA-binding protein RBM28 can translocate from the nucleolus to the nucleoplasm to inhibit the transcriptional activity of p53","volume":"298","author":"Lin","year":"2022","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.jneuroim.2026.579110_bb0140","doi-asserted-by":"crossref","first-page":"4785","DOI":"10.1007\/s12035-024-04588-5","article-title":"BTK and YKL-40 levels and their association with acute AQP4-IgG-positive neuromyelitis optica spectrum disorder","volume":"62","author":"Liu","year":"2024","journal-title":"Mol. Neurobiol."},{"issue":"1","key":"10.1016\/j.jneuroim.2026.579110_bb0145","doi-asserted-by":"crossref","first-page":"7526","DOI":"10.1038\/s41467-023-43113-5","article-title":"LncRNA INHEG promotes glioma stem cell maintenance and tumorigenicity through regulating rRNA 2'-O-methylation","volume":"14","author":"Liu","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jneuroim.2026.579110_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2022.109139","article-title":"CXCL7 aggravates the pathological manifestations of neuromyelitis optica spectrum disorder by enhancing the inflammatory infiltration of neutrophils, macrophages and microglia","volume":"245","author":"Liu","year":"2022","journal-title":"Clin. Immunol."},{"issue":"4","key":"10.1016\/j.jneuroim.2026.579110_bb0155","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.tmrv.2022.06.008","article-title":"New treatment perspectives for acute relapses in Neuromyelitis Optica Spectrum disorder","volume":"36","author":"Lotan","year":"2022","journal-title":"Transfus. Med. Rev."},{"key":"10.1016\/j.jneuroim.2026.579110_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2026.102016","article-title":"Therapeutic immune tolerance for central nervous system autoimmune diseases - prospects, challenges and pitfalls","volume":"81","author":"Lutterotti","year":"2026","journal-title":"Semin. Immunol."},{"issue":"1","key":"10.1016\/j.jneuroim.2026.579110_bb0165","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1186\/s12974-021-02266-0","article-title":"Regulatory T cells protect against brain damage by alleviating inflammatory response in neuromyelitis optica spectrum disorder","volume":"18","author":"Ma","year":"2021","journal-title":"J. Neuroinflammation"},{"issue":"3","key":"10.1016\/j.jneuroim.2026.579110_bb0170","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1097\/WCO.0000000000001052","article-title":"Pathomechanisms in demyelination and astrocytopathy: autoantibodies to AQP4, MOG, GFAP, GRP78 and beyond","volume":"35","author":"Mader","year":"2022","journal-title":"Curr. Opin. Neurol."},{"issue":"8","key":"10.1016\/j.jneuroim.2026.579110_bb0175","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.2280","article-title":"Clustered regularly interspaced short palindromic repeats as an advanced treatment for Parkinson's disease","volume":"11","author":"Mehmood","year":"2021","journal-title":"Brain Behav."},{"issue":"8","key":"10.1016\/j.jneuroim.2026.579110_bb0180","doi-asserted-by":"crossref","first-page":"4071","DOI":"10.1007\/s10571-023-01432-7","article-title":"Methyl-CpG-binding protein 2 emerges as a central player in multiple sclerosis and Neuromyelitis Optica Spectrum disorders","volume":"43","author":"Mehmood","year":"2023","journal-title":"Cell. Mol. Neurobiol."},{"issue":"3","key":"10.1016\/j.jneuroim.2026.579110_bb0185","first-page":"240","article-title":"LINE-1 retrotransposon activation drives age-associated inflammation via cytoplasmic cDNA-STING\/type I interferon signalling: therapeutic potential of reverse transcriptase inhibition","volume":"29","author":"Mehmood","year":"2025","journal-title":"Contemp Oncol (Pozn)"},{"issue":"3","key":"10.1016\/j.jneuroim.2026.579110_bb0190","article-title":"Novel aptamers targeting heparan sulfate for delivery of RNA therapeutics in Alzheimer's disease","volume":"8","author":"Mehmood","year":"2026","journal-title":"Prog Biomed Eng (Bristol)"},{"issue":"1","key":"10.1016\/j.jneuroim.2026.579110_bb0195","doi-asserted-by":"crossref","first-page":"63","DOI":"10.5114\/fn.2026.158745","article-title":"Neuroectodermal interleukin 12 signaling attenuates spinal cord inflammation and demyelination","volume":"64","author":"Mehmood","year":"2026","journal-title":"Folia Neuropathol."},{"key":"10.1016\/j.jneuroim.2026.579110_bb0200","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.neuropharm.2012.11.015","article-title":"An epigenetic framework for neurodevelopmental disorders: from pathogenesis to potential therapy","volume":"68","author":"Millan","year":"2013","journal-title":"Neuropharmacology"},{"issue":"8","key":"10.1016\/j.jneuroim.2026.579110_bb0205","first-page":"3961","article-title":"Microglia complement astrocytes in neuromyelitis optica","volume":"130","author":"Moinfar","year":"2020","journal-title":"J. Clin. Invest."},{"issue":"5","key":"10.1016\/j.jneuroim.2026.579110_bb0210","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/j.ajhg.2008.03.014","article-title":"Alopecia, neurological defects, and endocrinopathy syndrome caused by decreased expression of RBM28, a nucleolar protein associated with ribosome biogenesis","volume":"82","author":"Nousbeck","year":"2008","journal-title":"Am. J. Hum. Genet."},{"issue":"5","key":"10.1016\/j.jneuroim.2026.579110_bb0215","doi-asserted-by":"crossref","DOI":"10.3390\/biom10050783","article-title":"snoRNPs: functions in ribosome biogenesis","volume":"10","author":"Ojha","year":"2020","journal-title":"Biomolecules"},{"issue":"10","key":"10.1016\/j.jneuroim.2026.579110_bb0010","volume":"11","year":"2021","journal-title":"Brain Behav."},{"issue":"4","key":"10.1016\/j.jneuroim.2026.579110_bb0220","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.rdc.2017.06.007","article-title":"Neuromyelitis optica","volume":"43","author":"Patterson","year":"2017","journal-title":"Rheum. Dis. Clin. N. Am."},{"issue":"1","key":"10.1016\/j.jneuroim.2026.579110_bb0225","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1093\/brain\/awad321","article-title":"Soluble TREM2 triggers microglial dysfunction in neuromyelitis optica spectrum disorders","volume":"147","author":"Qin","year":"2023","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.jneuroim.2026.579110_bb0230","doi-asserted-by":"crossref","DOI":"10.1186\/s43046-026-00394-3","article-title":"Nanotechnology-based immunotherapy: integrating artificial intelligence (AI) with current strategies in combating brain cancer disease","volume":"38","author":"Roslei","year":"2026","journal-title":"J. Egypt. Natl. Canc. Inst."},{"issue":"2","key":"10.1016\/j.jneuroim.2026.579110_bb0235","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1007\/s40120-021-00253-4","article-title":"Neuromyelitis Optica Spectrum disorder: clinical burden and cost of relapses and disease-related care in US clinical practice","volume":"10","author":"Royston","year":"2021","journal-title":"Neurol Ther"},{"issue":"9","key":"10.1016\/j.jneuroim.2026.579110_bb0240","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1038\/nm.4397","article-title":"Microglia emerge as central players in brain disease","volume":"23","author":"Salter","year":"2017","journal-title":"Nat. Med."},{"issue":"11","key":"10.1016\/j.jneuroim.2026.579110_bb0245","doi-asserted-by":"crossref","DOI":"10.26508\/lsa.202101154","article-title":"Expression of immunoglobulin constant domain genes in neurons of the mouse central nervous system","volume":"4","author":"Scheurer","year":"2021","journal-title":"Life Sci Alliance"},{"issue":"38","key":"10.1016\/j.jneuroim.2026.579110_bb0250","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000017184","article-title":"Comparison of psychiatric disturbances in patients with multiple sclerosis and neuromyelitis optica","volume":"98","author":"Shin","year":"2019","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"10.1016\/j.jneuroim.2026.579110_bb0255","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1111\/cns.13791","article-title":"Liraglutide attenuate central nervous inflammation and demyelination through AMPK and pyroptosis-related NLRP3 pathway","volume":"28","author":"Song","year":"2022","journal-title":"CNS Neurosci. Ther."},{"issue":"11","key":"10.1016\/j.jneuroim.2026.579110_bb0260","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1038\/onc.2013.89","article-title":"Elevated snoRNA biogenesis is essential in breast cancer","volume":"33","author":"Su","year":"2014","journal-title":"Oncogene"},{"key":"10.1016\/j.jneuroim.2026.579110_bb0265","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2019.00254","article-title":"Extracellular RNA in central nervous system pathologies","volume":"12","author":"Tielking","year":"2019","journal-title":"Front. Mol. Neurosci."},{"issue":"8","key":"10.1016\/j.jneuroim.2026.579110_bb0270","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.18632\/aging.101922","article-title":"Impaired ribosome biogenesis: mechanisms and relevance to cancer and aging","volume":"11","author":"Turi","year":"2019","journal-title":"Aging (Albany NY)"},{"issue":"10","key":"10.1016\/j.jneuroim.2026.579110_bb0275","doi-asserted-by":"crossref","first-page":"7989","DOI":"10.1007\/s12035-024-04072-0","article-title":"Interferon regulatory factor 5 gene polymorphisms and mRNA expression levels are associated with Neuromyelitis Optica Spectrum disorder","volume":"61","author":"Wang","year":"2024","journal-title":"Mol. Neurobiol."},{"issue":"8","key":"10.1016\/j.jneuroim.2026.579110_bb0280","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1111\/exd.12737","article-title":"RBM28, a protein deficient in ANE syndrome, regulates hair follicle growth via miR-203 and p63","volume":"24","author":"Warshauer","year":"2015","journal-title":"Exp. Dermatol."},{"issue":"12-a Suppl","key":"10.1016\/j.jneuroim.2026.579110_bb0285","first-page":"S3","article-title":"Aligning payer and provider strategies with the latest evidence to optimize clinical outcomes for patients with neuromyelitis optica spectrum disorder","volume":"28","author":"Wingerchuk","year":"2022","journal-title":"J. Manag. Care Spec. Pharm."},{"issue":"2","key":"10.1016\/j.jneuroim.2026.579110_bb0290","doi-asserted-by":"crossref","DOI":"10.1093\/bib\/bbad007","article-title":"Genetic control of RNA editing in neurodegenerative disease","volume":"24","author":"Wu","year":"2023","journal-title":"Brief. Bioinform."},{"issue":"12","key":"10.1016\/j.jneuroim.2026.579110_bb0295","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1111\/cns.13738","article-title":"BLK polymorphisms and expression level in neuromyelitis optica spectrum disorder","volume":"27","author":"Yin","year":"2021","journal-title":"CNS Neurosci. Ther."},{"issue":"7","key":"10.1016\/j.jneuroim.2026.579110_bb0300","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1038\/ncb3563","article-title":"AML1-ETO requires enhanced C\/D box snoRNA\/RNP formation to induce self-renewal and leukaemia","volume":"19","author":"Zhou","year":"2017","journal-title":"Nat. Cell Biol."},{"issue":"1","key":"10.1016\/j.jneuroim.2026.579110_bb0305","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s11064-026-04685-y","article-title":"AQP4-IgG-induced astrocyte-derived small extracellular vesicles carrying mitochondrial DNA regulate the TLR9\/MyD88\/NF-\u03baB pathway to drive microglial activation and Neuromyelitis Optica","volume":"51","author":"Zhou","year":"2026","journal-title":"Neurochem. Res."},{"issue":"4","key":"10.1016\/j.jneuroim.2026.579110_bb0310","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/j.celrep.2019.03.083","article-title":"Noc4L-mediated ribosome biogenesis controls activation of regulatory and conventional T cells","volume":"27","author":"Zhu","year":"2019","journal-title":"Cell Rep."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572826002596?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572826002596?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T08:23:52Z","timestamp":1793175832000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572826002596"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,1]]},"references-count":62,"alternative-id":["S0165572826002596"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2026.579110","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2027,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"NOP58 knockdown in microglia is associated with reduced neuroinflammation and synaptic damage in NMOSD","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2026.579110","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"579110"}}